It is reported that BMSCs-derived EVs suppress immune function in multiple myeloma by activating MDSCs through the STAT3/STAT1 signaling pathway, thereby promoting the development of multiple myeloma (87). This evidence concerns the gene STAT1 and AL amyloidosis.